The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Mark A. Boyd

Department of Microbiology and Infectious Diseases

Flinders Medical Centre




Name/email consistency: high



  • Department of Microbiology and Infectious Diseases, Flinders Medical Centre, Adelaide, Australia. 2006 - 2007
  • The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Thai Red Cross AIDS Research Centre, Bangkok, Thailand. 2005 - 2006


  1. A febrile illness with generalized papular rash involving the palms and soles. Boyd, M.A., Menon, P., Graves, S., Gordon, D.L. Clin. Infect. Dis. (2007) [Pubmed]
  2. Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir. Boyd, M.A., Srasuebkul, P., Ruxrungtham, K., Mackenzie, P.I., Uchaipichat, V., Stek, M., Lange, J.M., Phanuphak, P., Cooper, D.A., Udomuksorn, W., Miners, J.O. Pharmacogenet. Genomics (2006) [Pubmed]
  3. Pandemic influenza: clinical issues. Boyd, M., Clezy, K., Lindley, R., Pearce, R. Med. J. Aust. (2006) [Pubmed]
  4. The use of pharmacokinetically guided indinavir dose reductions in the management of indinavir-associated renal toxicity. Boyd, M.A., Siangphoe, U., Ruxrungtham, K., Reiss, P., Mahanontharit, A., Lange, J.M., Phanuphak, P., Cooper, D.A., Burger, D.M. J. Antimicrob. Chemother. (2006) [Pubmed]
  5. Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005). Boyd, M.A., Srasuebkul, P., Khongphattanayothin, M., Ruxrungtham, K., Hassink, E.A., Duncombe, C.J., Ubolyam, S., Burger, D.M., Reiss, P., Stek, M., Lange, J., Cooper, D.A., Phanuphak, P. Antivir. Ther. (Lond.) (2006) [Pubmed]
  6. Changes in body composition and mitochondrial nucleic acid content in patients switched from failed nucleoside analogue therapy to ritonavir-boosted indinavir and efavirenz. Boyd, M.A., Carr, A., Ruxrungtham, K., Srasuebkul, P., Bien, D., Law, M., Wangsuphachart, S., Krisanachinda, A., Lerdlum, S., Lange, J.M., Phanuphak, P., Cooper, D.A., Reiss, P. J. Infect. Dis. (2006) [Pubmed]
  7. The long-term consequences of antiretroviral therapy: a review. Boyd, M., Reiss, P. J. HIV. Ther (2006) [Pubmed]
  8. Viral decay dynamics in HIV-infected patients receiving ritonavir-boosted saquinavir and efavirenz with or without enfuvirtide: a randomized, controlled trial (HIV-NAT 012). Boyd, M.A., Dixit, N.M., Siangphoe, U., Buss, N.E., Salgo, M.P., Lange, J.M., Phanuphak, P., Cooper, D.A., Perelson, A.S., Ruxrungtham, K. J. Infect. Dis. (2006) [Pubmed]
  9. Indinavir/ritonavir 800/100 mg bid and efavirenz 600 mg qd in patients failing treatment with combination nucleoside reverse transcriptase inhibitors: 96-week outcomes of HIV-NAT 009. Boyd, M.A., Siangphoe, U., Ruxrungtham, K., Duncombe, C.J., Stek, M., Lange, J.M., Cooper, D.A., Phanuphak, P. HIV Med. (2005) [Pubmed]
WikiGenes - Universities